Lauren Nawrocki helps patients use Saxenda safely and effectively as part of their weight loss journey
5.4 Use in Women of Childbearing Potential Because of the risk to the fetus of decreased IQ, neurodevelopmental disorders, and major congenital malformations (including neural tube defects), which may occur very early in pregnancy, valproate should not be administered to a woman of childbearing potential unless other medications have failed to provide adequate symptom control or are otherwise unacceptable
Efficacy, safety, and tolerability of exenatide once weekly in patients with type 2 diabetes mellitus: an integrated analysis of the DURATION trials
This review looks at Medvis weight-loss offering as a whole: the compounds it uses, how care is delivered, what it costs, and the individual variable that explains why two people on the same plan can differ
There is also a risk of worsening diabetic retinopathy with rapid improvement in blood glucose control
Ho M, Marger M, Beart J, Yip I, Shekelle P